Few recent estimates of childhood asthma incidence exist in the literature, although the importance of incidence surveillance for understanding asthma risk factors has been recognized. Asthma prevalence, morbidity, and mortality reports have repeatedly shown that low-income children are disproportionately impacted by the disease. The aim of this study was to demonstrate the utility of Medicaid claims data for providing statewide estimates of asthma incidence. Medicaid analytic extract (MAX) data for Texas children aged 0-17 years enrolled in Medicaid between 2004 and 2007 were used to estimate incidence overall and by age group, gender, race, and county of residence. A ≥13-month period of continuous enrollment was required in order to distinguish incident from prevalent cases identified in the claims data. The age-adjusted incidence of asthma was 4.26/100 person-years during 2005-2007, higher than reported in other populations. Incidence rates decreased with age, were higher for males than females, differed by race, and tended to be higher in rural than urban areas. This study demonstrates the utility of Medicaid analytic extract data for estimating asthma incidence and describes the methodology required for a population with unstable enrollment. asthma; child; incidence; Medicaid Abbreviations: CI, confidence interval; MAX, Medicaid analytic extract.
Nearly 10% of children in the United States had asthma in 2009 (1) . Asthma is a leading cause of illness and hospitalizations among children, with significant impacts on health and quality of life. Direct and indirect costs of asthma are substantial, from increased medical care to missed school days (1, 2) . Low-income children are disproportionately impacted, accounting for 37% of the US population but 58% of prevalent asthma cases (3) . Medicaidenrolled children have higher risk of asthma-related morbidity, complications, and hospitalization than do privately insured children (4) (5) (6) .
Although asthma prevalence and morbidity are well described, estimates of childhood asthma incidence are rare. Rudd and Moorman (7) estimated annual asthma incidence in US children ranging from 5.7/1,000 in 1980 to 10.1/ 1,000 in 1995. A recent Canadian study reported incidence in 2004-2005 ranging from 31.3/1,000 person-years for children under 5 to 5.6/1,000 person-years in children aged 10-14 years (8) . Others have reported incidence rates in children ranging from 8.4/1,000 person-years to 24.6/1,000 person-years (9, 10) .
Medicaid provides health and long-term-care coverage to nearly 60 million low-income and disabled Americans, including 30% of US children, and is funded jointly by state and federal governments (11) . Broad federal guidelines mandate that states cover certain benefits like hospital and physician services, but other benefits are optional, including prescription drug coverage. States set eligibility criteria and cost-sharing requirements, within federal standards (12) .
Medicaid claims data have been used to describe asthma prevalence, morbidity, and health-care utilization patterns (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) . Although 2 studies estimated asthma incidence using claims data (8, 23) , we found none that used Medicaid data to estimate national-or state-level incidence. Thus, we conducted this investigation to demonstrate the utility of Medicaid claims data for estimating asthma incidence among Texas children enrolled in Medicaid, a population of over 2.5 million (24) .
MATERIALS AND METHODS
We used Medicaid analytic extract (MAX) files produced by the Centers for Medicare and Medicaid Services specifically for research. MAX files contain annual, person-level data on Medicaid eligibility and health-care utilization reported by the states. The files contain final adjudicated claims by date of service and have undergone quality checks and corrections (25, 26 
Identification of study population
The personal summary files contained indicators that were used to determine which months each child was enrolled and eligible for the full scope of Medicaid benefits, until his/her 18th birthday. Even if enrolled, children were considered ineligible during any year they had private insurance coverage, as this could result in incomplete claims history. Children with only premium (i.e., capitated) payment claims during the year were also considered ineligible to eliminate followup time during which no medical or pharmacy claims would be found in the MAX files. Once eligible, months were determined for each child, and the 4 personal summary files were combined into a single enrollment file (Figure 1) .
The beginning and ending months for each child's period(s) of enrollment were derived from the combined, 4-year enrollment file. Children were included in the study population if they had one or more continuous ≥13-month span of enrollment between 2004 and 2007, allowing for a single 1-month enrollment gap during the 4-year period. This continuous enrollment span provided a "wash-out" period that enabled us to distinguish incident from prevalent cases.
Identification of asthma cases
We combined all medical and pharmacy claims for the 4-year period and defined cases as children with a primary diagnosis of asthma (International Classification of Diseases, Ninth Revision, code 493.xx) on one or more outpatient or inpatient records or 4 or more asthma medication (27) dispensing events (30-day supply) during a 365-day period. For a medication prescription with more than 30 days' supply, we divided days by 30 and rounded up to calculate the number of 30-day dispensing events. For each case, the earliest of either date of service for the first asthma medical claim or prescribed date of the first asthma prescription dispensed was kept as the date of diagnosis.
Analysis
Records from the enrollment and case files were joined, and cases without an enrollment record (i.e., did not have a ≥13-month span of continuous enrollment between 2004 and 2007) were excluded. We also excluded cases that were in the enrollment file but not enrolled continuously in the 12-month period prior to diagnosis, as we could not determine whether these were incident or prevalent cases. For the remaining study population, person-months were calculated beginning with the 13th month of follow-up (the first month in which a subject could become an incident case). Follow-up ended on the earliest of 1) the last month of the enrollment span, 2) the month of asthma diagnosis, or 3) December 31, 2007. Hence, person-months of follow-up ranged from 1 to 36. Personal summary and claims files from 2004 were not used in the analysis other than to provide a wash-out period for children in the 2005 files.
Asthma incidence rates were calculated for Texas overall and by age group (1-4, 5-9, 10-14, and 15-17 years), gender, race (white, black, Hispanic, Asian, American Analyses were performed by using SAS, version 9.2, software (SAS Institute, Inc., Cary, North Carolina). A map of county-specific incidence rates was generated with ArcGIS, version 10 (Esri, Redlands, California). from an outpatient record, and 91% of these also had at least one subsequent asthma medication claim. Fewer than 1% were identified through inpatient records. The remaining 25% received their diagnosis on the date they filled the first of 4 prescriptions, and of these, over 40% had a subsequent outpatient record. Overall age-adjusted asthma incidence in this population was 4.26 cases (95% confidence interval (CI): 4.23, 4.30) per 100 person-years. Incidence was higher in males than females and decreased with age. White children and black children had the highest incidence, while rates were lowest among Asians. Incidence rates for white males and black males approached 5 cases per 100 person-years. County-specific incidence rates were generally higher in southern border counties and lower in larger metropolitan areas (Figure 2) . Counties including Houston, Dallas, Fort Worth, Austin, and El Paso had incidence rates significantly below the statewide rate, from 3.08 (95% CI: 2.90, 3.27) to 3.95 (95% CI: 3.84, 4.06) per 100 person-years. Of the state's largest population centers, only Bexar County, which includes San Antonio, surpassed the state average with an incidence rate of 5.19 (95% CI: 5.06, 5.32) per 100 person-years. The 36 counties with fewer than 16 cases had total population sizes from 67 to 8,854, with between 2 and 474 children enrolled in Medicaid (24, 28) .
DISCUSSION
Forty percent of Texas children are enrolled in Medicaid, and the cost of asthma-related treatment for these children exceeded $242 million in 2004 (29) . On the basis of our analysis, Medicaid-enrolled children in Texas were newly diagnosed with asthma at a rate of 4.26/100 person-years between 2005 and 2007. Our estimates are higher than previously reported in the United States (7) and Canada (8) but not unexpected among low-income children. Incidence rates were higher for males and decreased with age, consistent with other reports (8, 9) . As in the Canadian study, we found that incidence rates were higher for males than females in the youngest age groups but similar in children aged 15-17 years (males = 2.8%, females = 3.0%). The median age at diagnosis was 4.9 years, consistent with clinical experience that most children with asthma will develop symptoms by the age of 5 years (30).
A higher incidence among whites than blacks was unexpected, as most prevalence studies report the reverse. Some (31, 32) but not all (33, 34) have shown a lessened effect of race on childhood asthma prevalence after adjustment for socioeconomic status. Our results may reflect lower health-care utilization among blacks, who generally have fewer primary care visits and more emergency room visits and inpatient hospital stays than whites (5, 19, 35, 36) . Although we identified few cases through inpatient claims, lower primary care visit rates could result in underestimated incidence among blacks.
The primary strengths of our study are the large sample size and 3-year timeframe that allowed estimation of stable rates by age group, gender, race/ethnicity, and county. We applied methodology previously used in cancer research (37) (38) (39) (40) (41) (42) (43) (44) (45) to estimate rates of newly occurring asthma, using a data source with both medical and pharmacy claims. The date of onset was determined directly from claims data and was not subject to recall bias. Requiring a ≥13-month continuous enrollment period without evidence of asthma decreased the likelihood of classifying prevalent cases as incident cases, particularly for a disease with seasonal morbidity patterns (46) .
Weaknesses of the study include the lack of a "gold standard" for measuring asthma incidence, making it difficult to validate this method. Our results are not generalizable to the general population in Texas, as they represent lowincome children with health insurance benefits. Incidence rate estimates across states using this methodology and data source may not be directly comparable because of differences in Medicaid eligibility, benefits, and coverage. The Medicaid population is fluid, resulting in variable lengths of follow-up and potential selection bias. Nearly 11% of children were enrolled for only 13 months, while 15% were enrolled for the entire 3-year period.
The inclusion of beneficiaries from capitated managedcare (health maintenance organization) plans and feefor-service plans may have introduced bias into our estimates. Although claims reporting for health maintenance organization plans improved over time, data completeness and quality likely differed between the 2 types of plans (47) . Most children in the 9 major metropolitan areas of Texas are required to enroll in a capitated program, whereas a fee-for-service program covers the rest of the state. It is unclear whether underreporting of health maintenance organization claims may have contributed to lower incidence rates in urban areas or to what extent statewide rates were underestimated. Lower asthma prevalence in urban areas has been reported among other Medicaid populations and may be partially attributable to higher smoking rates in rural areas (48) . We should note that pharmacy claims in Texas are paid on a fee-for-service basis. Although use of both medical and pharmacy records is the method preferred by the Centers for Medicare and Medicaid Services for identifying asthma cases, relying on pharmacy records alone can also provide reliable estimates (16) .
The Centers for Disease Control and Prevention has called for a greater emphasis on tracking incidence in US asthma surveillance programs, while acknowledging the inherent challenges and limited data sources (49, 50) . In this unique study, we estimated population-based asthma incidence using statewide Medicaid claims data, a rich source for studying diseases disproportionately impacting lowincome children. Our results indicate that Medicaidenrolled children are at greater risk of being given an asthma diagnosis than those in the general population. Knowledge of asthma incidence patterns is critical to understanding associated risk factors, and we hope that this novel approach will be applied to other Medicaid populations to increase understanding of this disabling and costly disease.
